000			01932 a2200541 4500
005			20250513174551.0
264		0	_c19990419
008			199904s 0 0 eng d
022			_a0735-1097
024	7		_a10.1016/s0735-1097(98)00695-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aHavranek, E P
245	0	0	_aDose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure. _h[electronic resource]
260			_bJournal of the American College of Cardiology _cApr 1999
300			_a1174-81 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAngiotensin Receptor Antagonists
650	0	4	_aAntihypertensive Agents _xadministration & dosage
650	0	4	_aBiphenyl Compounds _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHeart Failure _xblood
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHumans
650	0	4	_aIrbesartan
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNorepinephrine _xblood
650	0	4	_aReceptor, Angiotensin, Type 1
650	0	4	_aReceptor, Angiotensin, Type 2
650	0	4	_aSafety
650	0	4	_aSingle-Blind Method
650	0	4	_aTetrazoles _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aThomas, I
700	1		_aSmith, W B
700	1		_aPonce, G A
700	1		_aBilsker, M
700	1		_aMunger, M A
700	1		_aWolf, R A
773	0		_tJournal of the American College of Cardiology _gvol. 33 _gno. 5 _gp. 1174-81
856	4	0	_uhttps://doi.org/10.1016/s0735-1097(98)00695-0 _zAvailable from publisher's website
999			_c10153132 _d10153132